Convenio de Suministro de Fármacos No Incorporados a CENABAST 2 para el Hospital Provincial de Ovalle
Convenio de Suministro de Fármacos no Incorporados a Cenabast 2, para el Hospital Provincial de Ovalle
11 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 1058045-200-SE26 | 19-02-2026 | Astrazeneca S.A. | $3.696.735 |
| 1058045-88-SE26 | 19-01-2026 | Winpharm SpA | $892.500 |
| 1058045-1290-SE25 | 30-12-2025 | Astrazeneca S.A. | $862.572 |
| 1058045-1232-SE25 | 22-12-2025 | Guillermo Harding y Compania Limitada | $1.161.250 |
| 1058045-1242-SE25 | 22-12-2025 | Astrazeneca S.A. | $1.725.143 |
| 1058045-1164-SE25 | 21-11-2025 | Difem Laboratorios S.A. | $384.608 |
| 1058045-969-SE25 | 08-09-2025 | Guillermo Harding y Compania Limitada | $1.070.863 |
| 1058045-946-SE25 | 04-09-2025 | Astrazeneca S.A. | $2.341.266 |
| 1058045-947-SE25 | 04-09-2025 | Difem Laboratorios S.A. | $384.608 |
| 1058045-949-SE25 | 04-09-2025 | Winpharm SpA | $958.545 |
| 1058045-950-SE25 | 04-09-2025 | Guillermo Harding y Compania Limitada | $979.608 |
| 1058045-960-SE25 | 04-09-2025 | Laboratorio Chile S.A. | $12.138 |
| 1058045-819-SE25 | 10-07-2025 | Winpharm SpA | $357.000 |
| 1058045-821-SE25 | 10-07-2025 | Guillermo Harding y Compania Limitada | $653.072 |
| 1058045-708-SE25 | 27-05-2025 | Instituto Sanitas S.A. | $171.360 |
| 1058045-694-SE25 | 27-05-2025 | Laboratorio Chile S.A. | $29.607 |
| 1058045-695-SE25 | 26-05-2025 | Difem Laboratorios S.A. | $384.608 |
| 1058045-689-SE25 | 26-05-2025 | Astrazeneca S.A. | $2.341.266 |
| 1058045-598-SE25 | 22-04-2025 | Laboratorio Chile S.A. | $2.685 |
| 1058045-464-SE25 | 14-04-2025 | Guillermo Harding y Compania Limitada | $786.923 |
| 1058045-465-SE25 | 14-04-2025 | Winpharm SpA | $660.450 |
| 1058045-428-SE25 | 11-04-2025 | Difem Laboratorios S.A. | $144.228 |
| 1058045-416-SE25 | 27-03-2025 | Astrazeneca S.A. | $1.971.592 |
| 1058045-417-SE25 | 27-03-2025 | Guillermo Harding y Compania Limitada | $1.161.250 |
| 1058045-191-SE25 | 07-02-2025 | Winpharm SpA | $904.995 |
| 1058045-187-SE25 | 07-02-2025 | Difem Laboratorios S.A. | $144.228 |
| 1058045-189-SE25 | 06-02-2025 | Guillermo Harding y Compania Limitada | $1.837.873 |
| 1058045-186-SE25 | 05-02-2025 | Astrazeneca S.A. | $3.852.849 |
| 1058045-94-SE25 | 15-01-2025 | Guillermo Harding y Compania Limitada | $164.702 |
| 1058045-93-SE25 | 15-01-2025 | Laboratorio Chile S.A. | $2.685 |
| 1058045-95-SE25 | 15-01-2025 | Winpharm SpA | $357.000 |
| 1058045-1212-SE24 | 31-12-2024 | Astrazeneca S.A. | $1.232.245 |
| 1058045-1161-SE24 | 31-12-2024 | Difem Laboratorios S.A. | $576.912 |
| 1058045-1214-SE24 | 31-12-2024 | Guillermo Harding y Compania Limitada | $1.749.080 |
| 1058045-1188-SE24 | 17-12-2024 | Winpharm SpA | $958.545 |
| 1058045-1140-SE24 | 22-11-2024 | Guillermo Harding y Compania Limitada | $522.458 |
| 1058045-1135-SE24 | 22-11-2024 | Winpharm SpA | $242.760 |
| 1058045-1136-SE24 | 22-11-2024 | Astrazeneca S.A. | $1.725.143 |
| 1058045-625-SE24 | 30-10-2024 | Difem Laboratorios S.A. | $192.304 |
| 1058045-1076-SE24 | 30-10-2024 | Laboratorio Chile S.A. | $6.474 |
| 1058045-867-SE24 | 30-10-2024 | Instituto Sanitas S.A. | $85.680 |
| 1058045-868-SE24 | 30-10-2024 | Guillermo Harding y Compania Limitada | $457.150 |
| 1058045-869-SE24 | 30-10-2024 | Winpharm SpA | $357.000 |
| 1058045-1033-SE24 | 30-10-2024 | Guillermo Harding y Compania Limitada | $460.204 |
| 1058045-1067-SE24 | 30-10-2024 | Winpharm SpA | $47.600 |
| 1058045-1070-SE24 | 30-10-2024 | Astrazeneca S.A. | $862.572 |
| 1058045-893-SE24 | 09-10-2024 | Laboratorio Chile S.A. | $4.855 |
| 1058045-738-SE24 | 09-10-2024 | Astrazeneca S.A. | $1.725.143 |
| 1058045-758-SE24 | 09-10-2024 | Winpharm SpA | $285.600 |
| 1058045-710-SE24 | 26-08-2024 | Guillermo Harding y Compania Limitada | $1.189.597 |
| 1058045-644-SE24 | 10-07-2024 | Winpharm SpA | $958.545 |
| 1058045-668-SE24 | 10-07-2024 | Guillermo Harding y Compania Limitada | $1.307.641 |
| 1058045-757-SE24 | 10-07-2024 | Astrazeneca S.A. | $956.017 |
| 1058045-643-SE24 | 09-07-2024 | Instituto Sanitas S.A. | $139.230 |
| 1058045-686-SE24 | 26-06-2024 | Astrazeneca S.A. | $823.237 |
| 1058045-627-SE24 | 31-05-2024 | Laboratorio Chile S.A. | $6.731 |
| 1058045-454-SE24 | 18-04-2024 | Laboratorio Chile S.A. | $11.253 |
| 1058045-453-SE24 | 18-04-2024 | Astrazeneca S.A. | $5.136.095 |
| 1058045-455-SE24 | 18-04-2024 | Guillermo Harding y Compania Limitada | $1.373.574 |
| 1058045-456-SE24 | 18-04-2024 | Winpharm SpA | $1.273.300 |
| 1058045-295-SE24 | 14-03-2024 | Guillermo Harding y Compania Limitada | $348.384 |
| 1058045-296-SE24 | 14-03-2024 | Guillermo Harding y Compania Limitada | $424.497 |
| 1058045-297-SE24 | 14-03-2024 | Laboratorio Chile S.A. | $12.681 |
| 1058045-315-SE24 | 14-03-2024 | Astrazeneca S.A. | $788.637 |
| 1058045-316-SE24 | 14-03-2024 | Distribuidora Qualimed Limitada | $170.077 |
| 1058045-317-SE24 | 14-03-2024 | Winpharm SpA | $880.600 |
| 1058045-260-SE24 | 22-02-2024 | Astrazeneca S.A. | $2.649.327 |
| 1058045-208-SE24 | 16-02-2024 | Instituto Sanitas S.A. | $139.230 |
| 1058045-209-SE24 | 15-02-2024 | Laboratorio Chile S.A. | $130.955 |
| 1058045-210-SE24 | 15-02-2024 | Guillermo Harding y Compania Limitada | $1.441.753 |
| 1058045-211-SE24 | 15-02-2024 | Winpharm SpA | $1.743.945 |
| 1058045-184-SE24 | 14-02-2024 | Difem Laboratorios S.A. | $384.608 |
| 1058045-81-SE24 | 12-01-2024 | Difem Laboratorios S.A. | $384.608 |
| 1058045-82-SE24 | 12-01-2024 | Distribuidora Qualimed Limitada | $235.491 |
| 1058045-85-SE24 | 12-01-2024 | Guillermo Harding y Compania Limitada | $1.536.925 |
| 1058045-80-SE24 | 11-01-2024 | Laboratorio Chile S.A. | $158.996 |
Fuente original:ficha mercadopublico.cl
